Amgen has switched its $47 million consumer advertising account from
Euro RSCG to Abelson-Taylor in Chicago, according to a rep for
Abelson.
The Chicago agency already handled medical professional duties on the
brand. Along with the Neulasta, Abelson also picked up Amgen's
Aranesp brand, another cancer drug that has minimal consumer ad
spending.
<http://brandweek.com/bw/news/pharmaceutical/article_display.jsp?vnu_content_id=1001883967&imw=Y&imw=Y>
No comments:
Post a Comment